Nearly two decades after the iconic Motorola Razr V3 fused technology with fashion, Motorola and Paris Hilton are back ...
So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...
Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...
Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...
Stocks are marking daily gains, but it's nothing to write home about as investors await an update on tariffs while readying ...
Stocks started rising as the day unfolded with Fed Chair Jerome Powell reinforcing that interest rates remain in a "good ...
“Last year, 145,000 customers came through the restaurant,” fourth-generation owner and Musso & Frank Chief Financial Officer ...
A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last ...
Plastic is the most prevalent marine pollutant, and plastic surfaces are the fastest growing habitat in the ocean. Researchers at the University of Hawai'i (UH) at Mānoa have recently discovered ...
Feb. 11, 2025 — A recent study by two biological science researchers found that a pathogen for bird pink eye remained viable on bird feeders in winter months much ... 'Junk' RNA Segments Play ...
Genetic engineering is the act of modifying the genetic makeup of an organism. Modifications can be generated by methods such as gene targeting, nuclear transplantation, transfection of synthetic ...
WASHINGTON — Driven by the spread of CRISPR gene-editing techniques and rapid advances in AI-powered biochemical models, biotechnology is taking off. But not all biotech is equal in an investor ...